NKMAX Co., Ltd. – Trademark Portfolio
Entity Type: 03
NKMAX Co., Ltd. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include SNK, NKMAX, NK VUE, SUPERNK, and NKMAXBIO. The owner is based in Gyeonggi-do.
6F/1F SNUH Health Care Innovation Park
172, Dolma-ro, Bundang-gu, Seongnam-si
Gyeonggi-do 13605 , KR
Showing of trademarks Trademarks
Trademark Classifications
NKMAX Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NKMAX Co., Ltd. have?
NKMAX Co., Ltd. has 12 U.S. trademarks filed with the USPTO. Of these, 10 registered, 2 cancelled.
What trademark classes does NKMAX Co., Ltd. file in?
NKMAX Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NKMAX Co., Ltd.'s most well-known trademarks?
NKMAX Co., Ltd.'s registered trademark portfolio includes well-known marks such as SNK, NKMAX, NK VUE, SUPERNK, and NKMAXBIO. These are among 10 currently registered trademarks in the portfolio.
What is NKMAX Co., Ltd.'s trademark registration success rate?
NKMAX Co., Ltd. has a 83% trademark registration rate, with 10 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.